Latest News and Press Releases
Want to stay updated on the latest news?
-
Route 92 Medical and Q'Apel Medical have settled their patent litigation.
-
Route 92 Medical receives Australian Therapeutic Goods Administration approval for its portfolio of neurovascular interventional products.
-
First-of-its-kind multicenter study demonstrates the utility of the Monopoint system in procedures to treat idiopathic intracranial hypertension.
-
Route 92 Medical announces $50 million series F extension equity financing to support its commercial expansion.
-
Route 92 Medical announces the commercial launch of its FreeClimb 88 catheter system.
-
Route 92 Medical announces FDA 510(k) clearance for its FreeClimb 54 reperfusion system, part of its growing portfolio of neurovascular devices.
-
Route 92 Medical announces completion of enrollment in the SUMMIT MAX clinical trial studying their .088" HiPoint Reperfusion Catheter.
-
Route 92 Medical raises over $31 million in oversubscribed Series F equity financing to accelerate its commercialization.